Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND PDGFRB, JTK12, 5159, P09619, ENSG00000113721, PDGF-R-beta, PDGFR1, CD140B, PDGFR, CD140b AND Prognosis
11 results:

  • 1. Regorafenib and glioblastoma: a literature review of preclinical studies, molecular mechanisms and clinical effectiveness.
    Mongiardi MP; Pallini R; D'Alessandris QG; Levi A; Falchetti ML
    Expert Rev Mol Med; 2024 Apr; 26():e5. PubMed ID: 38563164
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Machine Learning Predicts the Oxidative Stress Subtypes Provide an Innovative Insight into colorectal cancer.
    Zhong H; Yang L; Zeng Q; Chen W; Zhao H; Wu L; Qin L; Yu QQ
    Oxid Med Cell Longev; 2023; 2023():1737501. PubMed ID: 37122535
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Dysregulated pdgfr alpha expression and novel somatic mutations in colorectal cancer: association to RAS wild type status and tumor size.
    Ben Jemii N; Tounsi-Kettiti H; Yaiche H; Mezghanni N; Jaballah Gabteni A; Fehri E; Ben Fayala C; Abdelhak S; Boubaker S
    J Transl Med; 2020 Nov; 18(1):440. PubMed ID: 33213472
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Targeting tumor cell-derived CCL2 as a strategy to overcome Bevacizumab resistance in ETV5
    Feng H; Liu K; Shen X; Liang J; Wang C; Qiu W; Cheng X; Zhao R
    Cell Death Dis; 2020 Oct; 11(10):916. PubMed ID: 33099574
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. PAI1 is a Marker of Bad prognosis in Rectal cancer but Predicts a Better Response to Treatment with PIM Inhibitor AZD1208.
    Muñoz-Galván S; Rivero M; Peinado-Serrano J; Martinez-Pérez J; Fernández-Fernández MC; Ortiz MJ; García-Heredia JM; Carnero A
    Cells; 2020 Apr; 9(5):. PubMed ID: 32344898
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Human UTP14a promotes angiogenesis through upregulating PDGFA expression in colorectal cancer.
    Ren P; Sun X; Zhang C; Wang L; Xing B; Du X
    Biochem Biophys Res Commun; 2019 May; 512(4):871-876. PubMed ID: 30929921
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer.
    Sandberg TP; Stuart MPME; Oosting J; Tollenaar RAEM; Sier CFM; Mesker WE
    BMC Cancer; 2019 Mar; 19(1):284. PubMed ID: 30922247
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Platelet‑derived growth factor receptor‑β gene expression relates to recurrence in colorectal cancer.
    Fujino S; Miyoshi N; Ohue M; Takahashi Y; Yasui M; Hata T; Matsuda C; Mizushima T; Doki Y; Mori M
    Oncol Rep; 2018 May; 39(5):2178-2184. PubMed ID: 29498405
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Molecular profiling of 6,892 colorectal cancer samples suggests different possible treatment options specific to metastatic sites.
    El-Deiry WS; Vijayvergia N; Xiu J; Scicchitano A; Lim B; Yee NS; Harvey HA; Gatalica Z; Reddy S
    Cancer Biol Ther; 2015; 16(12):1726-37. PubMed ID: 26553611
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The prognostic value of the Na⁺/ H⁺ exchanger regulatory factor 1 (NHERF1) protein in cancer.
    Saponaro C; Malfettone A; Dell'Endice TS; Brunetti AE; Achimas-Cadariu P; Paradiso A; Mangia A
    Cancer Biomark; 2014; 14(2-3):177-84. PubMed ID: 24878819
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Role of molecular subtypes in gastrointestinal stromal tumors in a clinical setting].
    Pan Z; Wu X; Jiang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Apr; 17(4):317-20. PubMed ID: 24760636
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.